Clinical Trial: Cromoglicate in Mastocytosis

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional

Official Title: A Phase II Exploratory Study Evaluating the Efficacy of Topical Cromoglicate Solution Compared to Topical Solution Vehicle in the Treatment of Mastocytosis

Brief Summary: The purpose of this exploratory study is to investigate the clinical efficacy of study drug (LP0074) in the treatment of Mastocytosis. The trial will be performed as a left/right comparison study in male/female subjects with mastocytosis, in a prospective, double-blinded, randomised, single centre setting.

Detailed Summary:
Sponsor: LEO Pharma

Current Primary Outcome: Evaluation of mechanically induced changes of lesions [ Time Frame: Baseline to week 2 ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Evaluation of mechanically induced wheal and flare response [ Time Frame: Baseline to week 2 ]

Original Secondary Outcome: Same as current

Information By: LEO Pharma

Dates:
Date Received: July 11, 2012
Date Started: October 2012
Date Completion:
Last Updated: March 6, 2013
Last Verified: March 2013